Boston Clinical Trials

Boston, Massachusetts 02135

4 studies enrolling now · 107 studies all time

What they study most

ADHD, Acne Vulgaris, Acute Migraine, Alzheimer Disease, Alzheimer's Disease, Binge Eating Disorder, Binge-Eating Disorder, Chronic Constipation, Chronic Idiopathic Constipation, Chronic Low Back Pain, Chronic Low-back Pain, Depressive Disorder, Major

Studies at this site

• A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis — Recruiting now
• An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets. — Recruiting now
• Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder — Recruiting now
• Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms — Recruiting now
• Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Recruiting now
• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy — Recruiting now
• A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain — Recruiting now
• Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension — Running, not enrolling
• Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Adjunctive Troriluzole in Obsessive-Compulsive Disorder — Completed
• Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications — Completed
• A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder — Running, not enrolling
• Long-term Safety and Tolerability of BHV-7000 — Enrolling by invitation
• Zelquistinel in the Treatment of Major Depressive Disorder — Completed
• Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use — Completed
• Comparison of Qutenza (8% Capsaicin) With a Low-dose Capsaicin for Treatment of Nerve Pain After Surgery — Completed
• To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications — Running, not enrolling
• A Study to Assess the Use of Methylone in the Treatment of PTSD — Completed
• Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) — Completed
• Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine — Completed
• A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures — Stopped early
• Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome — Completed
• Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder — Stopped early
• Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine — Completed
• A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease — Running, not enrolling
• A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine — Running, not enrolling
• Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder — Completed
• A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen — Completed
• Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression — Completed
• Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder — Completed
• A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling
• A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder — Completed
• ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder — Completed
• A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder — Completed
• Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention — Completed
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• BPL-003 Efficacy and Safety in Treatment Resistant Depression — Completed
• Study of V117957 in Overactive Bladder Syndrome — Completed
• A Study of Seltorexant in Participants With Probable Alzheimer's Disease — Completed
• A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early
• A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder. — Completed
• A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder — Completed
• A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Chronic Low Back Pain — Completed
• A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05). — Completed
• Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis — Completed
• A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
• A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain — Completed
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
• Randomized Trial of Adult Participants With Generalized Anxiety Disorder — Completed